Efficacy and Safety of Substitution of Glucocorticoid for BDB-001 Injection in Patients With Anti-neutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis

NCT05197842 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

ANCA-associated Vasculitis

Interventions

DRUG: BDB-001 injection
DRUG: Cyclophosphamide
DRUG: Glucocorticoids

Sponsor

Staidson (Beijing) Biopharmaceuticals Co., Ltd